PARIS--(BUSINESS WIRE)--Spotlight Medical, spinoff of Institut Curie, proudly announced its official launch. This innovative startup aims to transform cancer treatment using advanced artificial intelligence (AI), leveraging a unique technology developed by researchers and clinicians from Institut Curie, Mines Paris – PSL, and Inserm, over several years..

巴黎——（商业新闻短讯）——居里研究所（Institut Curie）的附属机构Spotlight Medical骄傲地宣布正式推出。这家创新创业公司旨在利用居里研究所（Institut Curie）、巴黎矿山（Mines Paris–PSL）和Inserm的研究人员和临床医生多年来开发的独特技术，利用先进人工智能（AI）改造癌症治疗。。

Founded by a physician, an AI researcher, and an entrepreneur, Spotlight Medical addresses the critical issue of inadequate cancer treatments. Many patients face over- or undertreatment, leading to reduced survival rates and unnecessary side effects. The founders believe that patient data holds untapped potential, which AI can harness to significantly improve patient care by identifying the most appropriate treatment for each individual..

Spotlight Medical由一位医生、一位人工智能研究人员和一位企业家创立，致力于解决癌症治疗不足的关键问题。许多患者面临过度或不足的治疗，导致生存率降低和不必要的副作用。创始人认为，患者数据具有未开发的潜力，人工智能可以通过为每个人确定最合适的治疗方法来显着改善患者护理。。

'Our incredibly powerful and innovative technology has unlocked unprecedented capabilities in tailoring cancer treatments,” said Sylvain Berlemont, co-founder and CEO of Spotlight Medical. “The potential impact on patient survival rates and quality of life is immense, heralding a new era in personalized cancer treatment.

Spotlight Medical联合创始人兼首席执行官西尔文·贝伦蒙（SylvainBerlemont）表示：“我们强大而创新的技术在定制癌症治疗方面开启了前所未有的能力。”。“对患者生存率和生活质量的潜在影响是巨大的，预示着个性化癌症治疗的新时代。

Our mission is to make it a reality—for patients and their families.”.

我们的使命是为患者及其家人实现这一目标。”。

Spotlight Medical’s clinical AI tests extract meaningful biological information from patient data within a secure and regulated framework. This data predicts treatment response efficacy, guiding oncologists in selecting the most suitable options for their patients. The technology is versatile, capable of handling various cancer types, with the first test focusing on a specific use case to be announced soon..

Spotlight Medical的临床AI测试在一个安全且受监管的框架内从患者数据中提取有意义的生物学信息。这些数据预测治疗反应的疗效，指导肿瘤学家为患者选择最合适的选择。该技术用途广泛，能够处理各种癌症类型，第一次测试集中在即将公布的特定用例上。。

The strategic alliance between Institut Curie and Spotlight Medical combines clinical expertise, extensive clinical data, advanced technology, and industrial resources to accelerate the development and implementation of innovative cancer solutions.

居里研究所和Spotlight Medical之间的战略联盟结合了临床专业知识、广泛的临床数据、先进技术和工业资源，以加速创新癌症解决方案的开发和实施。

“The launch of Spotlight Medical, based on the pioneer work conducted in Institut Curie’s lab and leveraged by Institut Curie’s clinical data, is further proof of our ability to develop high-potential entrepreneurial projects. Spotlight Medical is paving the way for a major, innovative, and promising improvement of patient treatments,” said Cécile Campagne, PhD, Director of Institut Curie’s Technology Transfer Office..

居里研究所技术转让办公室主任Cécile Campagne博士说：“Spotlight Medical的推出是基于居里研究所实验室开展的开创性工作，并利用居里研究所的临床数据，进一步证明了我们开发高潜力创业项目的能力。Spotlight Medical正在为重大、创新和有希望的患者治疗改进铺平道路。”。。

About Spotlight Medical

关于Spotlight Medical

Spotlight Medical is a precision medicine company striving to free all patients from cancer through a better understanding of each patient’s unique disease. We develop advanced AI tests that enhance treatment selection by leveraging decades of patient data. This ensures personalized and effective care for each individual, significantly improving patient outcomes and quality of life.

Spotlight Medical是一家精准医学公司，致力于通过更好地了解每位患者的独特疾病，使所有患者免于癌症。我们开发了先进的AI测试，通过利用数十年的患者数据来增强治疗选择。这确保了对每个人的个性化和有效护理，显着改善了患者的预后和生活质量。

By closely collaborating with physicians, we create impactful tests that address critical unmet clinical needs, opening a new era in cancer care..

通过与医生密切合作，我们创建了有影响力的测试，以解决关键的未满足临床需求，开创了癌症护理的新时代。。

For more information, visit spotlightmedical.com and follow us on LinkedIn and Twitter.

有关更多信息，请访问spotlightmedical.com，并在LinkedIn和Twitter上关注我们。

About Institut Curie

居里学院简介

Institut Curie, France’s leading cancer center, combines an internationally-renowned research center with a cutting-edge hospital group, treating all types of cancer, including the rarest. Founded in 1909 by Marie Curie, Institut Curie has 3 sites (Paris, Saint-Cloud and Orsay) with over 3,700 researchers, physicians and health professionals working on its 3 missions: treatment, research and teaching.

居里研究所（Institut Curie）是法国领先的癌症中心，它将国际知名的研究中心与尖端医院集团相结合，治疗各种类型的癌症，包括最罕见的癌症。居里研究所由玛丽·居里（MarieCurie）于1909年创建，拥有3个地点（巴黎、圣克劳德和奥赛），拥有3700多名研究人员、医生和卫生专业人员，致力于治疗、研究和教学三项任务。

A private foundation with public utility status, Institut Curie is authorized to accept donations and bequests, and thanks to the support of its donors, is able to accelerate discoveries and improve patient treatment and quality of life..

居里研究所是一家具有公共事业地位的私人基金会，被授权接受捐赠和遗赠，由于其捐赠者的支持，能够加速发现，改善患者治疗和生活质量。。

Find out more: www.curie.fr, Twitter, Facebook, LinkedIn, Instagram

了解更多信息：www.curie.fr、推特、脸书、LinkedIn、Instagram